NCT06366958 is a NA clinical trial of excision of dorsal wrist ganglion in Hand Ganglion, sponsored by Assiut University.

Who is sponsoring NCT06366958?

NCT06366958 is sponsored by Assiut University.

What drugs are being tested in NCT06366958?

Interventions in NCT06366958: excision of dorsal wrist ganglion.

What condition does NCT06366958 study?

NCT06366958 studies Hand Ganglion.

Is NCT06366958 still recruiting?

NCT06366958 is currently not yet recruiting. Last updated 16 April 2024.

Last reviewed 2024-04-16 · How we verify

NCT06366958

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arthroscopic Versus Open Excision of Dorsal Wrist Ganglion

Not yet recruiting NA Last updated 16 April 2024

What this trial tests

NA trial testing excision of dorsal wrist ganglion in Hand Ganglion in 46 participants. Not yet recruiting.

Timeline

2 May 2024

Primary endpoint
2 February 2025

2 April 2025

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	46
Start date	2 May 2024
Primary completion	2 February 2025
Estimated completion	2 April 2025

Drugs / interventions tested

excision of dorsal wrist ganglion

Conditions studied

Hand Ganglion — all drugs for Hand Ganglion →

Sponsor

Assiut University

Who can join

Adults 10 to 70, any sex, with Hand Ganglion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

compare recurrence rates after open and arthroscopic excision of dorsal wrist ganglion

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06366958 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 16 April 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06366958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing